Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Applied BioCode Corporation (6598.TW)

Compare
21.15
+0.30
+(1.44%)
At close: April 2 at 1:30:33 PM GMT+8

Key Executives

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Dr. Winston Z. Ho Ph.D. Founder, CEO, President & Director -- -- --
Mr. Jaca Liang-Kai Huang CFO & Corporate Governance Officer 6.17M -- --
Ms. Jau-Tung Pan Accounting Supervisor -- -- --
Yu-Tsung Chou Chief Information Officer -- -- --
Dr. Beth Laderman Ph.D. Chief Scientific Officer -- -- --
Ms. Parisa Hanachi Ph.D. Vice President of Marketing -- -- --
Mr. Jim Leigh Vice President of Sales -- -- --
Mr. Julian Sanchez Senior Director of Human Resources -- -- --
Ms. Ruei-E Tang Administration Division Director -- -- --
Ms. Ingrid Joseph Administration Division Director -- -- --

Applied BioCode Corporation

12130 Mora Dr.
Unit 2
Santa Fe Springs, CA 90670
United States
562 777 9800 https://www.apbiocode.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. It develops assays, such as BioCode SARS-CoV-2 Assay, a nucleic acid assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; and CoV-2 Flu Assay for detection of RNA and various Influenza, as well as offers gastrointestinal and respiratory pathogen panel related products. In addition, the company provides general purpose reagents and manufactures 28 fungal analyte specific reagents. Further, it offers barcoded bead related accessories. Applied BioCode Corporation is based in Santa Fe Springs, California.

Corporate Governance

Applied BioCode Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 10:59 AM UTC - May 16, 2025 at 12:00 PM UTC

Applied BioCode Corporation Earnings Date

Recent Events

Related Tickers